Consulting Services
Compare Stocks
2 / 10Stock Comparison
EXPO vs CRAI
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
EXPO vs CRAI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Consulting Services | Consulting Services |
| Market Cap | $3.16B | $999M |
| Revenue (TTM) | $582M | $752M |
| Net Income (TTM) | $106M | $55M |
| Gross Margin | 40.1% | 22.7% |
| Operating Margin | 20.6% | 11.1% |
| Forward P/E | 31.2x | 18.5x |
| Total Debt | $83M | $76M |
| Cash & Equiv. | $222M | $18M |
EXPO vs CRAI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Exponent, Inc. (EXPO) | 100 | 86.5 | -13.5% |
| CRA International, … (CRAI) | 100 | 377.9 | +277.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EXPO vs CRAI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EXPO is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 13 yrs, beta 0.89, yield 1.9%
- Lower volatility, beta 0.89, Low D/E 21.2%, current ratio 2.40x
- Beta 0.89, yield 1.9%, current ratio 2.40x
CRAI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 9.3%, EPS growth 20.8%, 3Y rev CAGR 8.3%
- 6.2% 10Y total return vs EXPO's 191.0%
- PEG 0.86 vs EXPO's 5.25
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.3% revenue growth vs EXPO's 4.2% | |
| Value | Lower P/E (18.5x vs 31.2x), PEG 0.86 vs 5.25 | |
| Quality / Margins | 18.2% margin vs CRAI's 7.3% | |
| Stability / Safety | Beta 0.73 vs EXPO's 0.89 | |
| Dividends | 1.9% yield, 13-year raise streak, vs CRAI's 1.3% | |
| Momentum (1Y) | -11.9% vs EXPO's -13.0% | |
| Efficiency (ROA) | 13.7% ROA vs CRAI's 8.7%, ROIC 36.3% vs 22.3% |
EXPO vs CRAI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EXPO vs CRAI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
EXPO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CRAI and EXPO operate at a comparable scale, with $752M and $582M in trailing revenue. EXPO is the more profitable business, keeping 18.2% of every revenue dollar as net income compared to CRAI's 7.3%. On growth, CRAI holds the edge at +11.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $582M | $752M |
| EBITDAEarnings before interest/tax | $125M | $109M |
| Net IncomeAfter-tax profit | $106M | $55M |
| Free Cash FlowCash after capex | $122M | $19M |
| Gross MarginGross profit ÷ Revenue | +40.1% | +22.7% |
| Operating MarginEBIT ÷ Revenue | +20.6% | +11.1% |
| Net MarginNet income ÷ Revenue | +18.2% | +7.3% |
| FCF MarginFCF ÷ Revenue | +21.0% | +2.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.8% | +11.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.5% | -8.7% |
Valuation Metrics
CRAI leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 18.8x trailing earnings, CRAI trades at a 40% valuation discount to EXPO's 31.0x P/E. Adjusting for growth (PEG ratio), CRAI offers better value at 0.87x vs EXPO's 5.21x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.2B | $999M |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $1.1B |
| Trailing P/EPrice ÷ TTM EPS | 31.02x | 18.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 31.24x | 18.52x |
| PEG RatioP/E ÷ EPS growth rate | 5.21x | 0.87x |
| EV / EBITDAEnterprise value multiple | 23.28x | 10.87x |
| Price / SalesMarket cap ÷ Revenue | 5.43x | 1.33x |
| Price / BookPrice ÷ Book value/share | 8.43x | 4.80x |
| Price / FCFMarket cap ÷ FCF | 25.85x | 53.86x |
Profitability & Efficiency
EXPO leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
CRAI delivers a 25.6% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $26 for EXPO. EXPO carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to CRAI's 0.36x. On the Piotroski fundamental quality scale (0–9), EXPO scores 6/9 vs CRAI's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +25.5% | +25.6% |
| ROA (TTM)Return on assets | +13.7% | +8.7% |
| ROICReturn on invested capital | +36.3% | +22.3% |
| ROCEReturn on capital employed | +19.2% | +26.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.21x | 0.36x |
| Net DebtTotal debt minus cash | -$139M | $58M |
| Cash & Equiv.Liquid assets | $222M | $18M |
| Total DebtShort + long-term debt | $83M | $76M |
| Interest CoverageEBIT ÷ Interest expense | — | 23.90x |
Total Returns (Dividends Reinvested)
CRAI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRAI five years ago would be worth $19,067 today (with dividends reinvested), compared to $7,312 for EXPO. Over the past 12 months, CRAI leads with a -11.9% total return vs EXPO's -13.0%. The 3-year compound annual growth rate (CAGR) favors CRAI at 19.0% vs EXPO's -8.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -8.0% | -23.6% |
| 1-Year ReturnPast 12 months | -13.0% | -11.9% |
| 3-Year ReturnCumulative with dividends | -23.5% | +68.5% |
| 5-Year ReturnCumulative with dividends | -26.9% | +90.7% |
| 10-Year ReturnCumulative with dividends | +191.0% | +619.1% |
| CAGR (3Y)Annualised 3-year return | -8.6% | +19.0% |
Risk & Volatility
Evenly matched — EXPO and CRAI each lead in 1 of 2 comparable metrics.
Risk & Volatility
CRAI is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than EXPO's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EXPO currently trades 78.4% from its 52-week high vs CRAI's 67.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 0.73x |
| 52-Week HighHighest price in past year | $81.95 | $227.29 |
| 52-Week LowLowest price in past year | $63.25 | $142.99 |
| % of 52W HighCurrent price vs 52-week peak | +78.4% | +67.2% |
| RSI (14)Momentum oscillator 0–100 | 45.7 | 54.7 |
| Avg Volume (50D)Average daily shares traded | 455K | 185K |
Analyst Outlook
EXPO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates EXPO as "Buy" and CRAI as "Buy". Consensus price targets imply 32.4% upside for EXPO (target: $85) vs 27.1% for CRAI (target: $194). For income investors, EXPO offers the higher dividend yield at 1.87% vs CRAI's 1.35%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $85.00 | $194.00 |
| # AnalystsCovering analysts | 8 | 1 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | +1.3% |
| Dividend StreakConsecutive years of raises | 13 | 9 |
| Dividend / ShareAnnual DPS | $1.20 | $2.06 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.1% | +4.7% |
EXPO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CRAI leads in 2 (Valuation Metrics, Total Returns). 1 tied.
EXPO vs CRAI: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is EXPO or CRAI a better buy right now?
For growth investors, CRA International, Inc.
(CRAI) is the stronger pick with 9. 3% revenue growth year-over-year, versus 4. 2% for Exponent, Inc. (EXPO). CRA International, Inc. (CRAI) offers the better valuation at 18. 8x trailing P/E (18. 5x forward), making it the more compelling value choice. Analysts rate Exponent, Inc. (EXPO) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EXPO or CRAI?
On trailing P/E, CRA International, Inc.
(CRAI) is the cheapest at 18. 8x versus Exponent, Inc. at 31. 0x. On forward P/E, CRA International, Inc. is actually cheaper at 18. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CRA International, Inc. wins at 0. 86x versus Exponent, Inc. 's 5. 25x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EXPO or CRAI?
Over the past 5 years, CRA International, Inc.
(CRAI) delivered a total return of +90. 7%, compared to -26. 9% for Exponent, Inc. (EXPO). Over 10 years, the gap is even starker: CRAI returned +619. 1% versus EXPO's +191. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EXPO or CRAI?
By beta (market sensitivity over 5 years), CRA International, Inc.
(CRAI) is the lower-risk stock at 0. 73β versus Exponent, Inc. 's 0. 89β — meaning EXPO is approximately 21% more volatile than CRAI relative to the S&P 500. On balance sheet safety, Exponent, Inc. (EXPO) carries a lower debt/equity ratio of 21% versus 36% for CRA International, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EXPO or CRAI?
By revenue growth (latest reported year), CRA International, Inc.
(CRAI) is pulling ahead at 9. 3% versus 4. 2% for Exponent, Inc. (EXPO). On earnings-per-share growth, the picture is similar: CRA International, Inc. grew EPS 20. 8% year-over-year, compared to -1. 9% for Exponent, Inc.. Over a 3-year CAGR, CRAI leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EXPO or CRAI?
Exponent, Inc.
(EXPO) is the more profitable company, earning 18. 2% net margin versus 7. 3% for CRA International, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXPO leads at 20. 6% versus 11. 1% for CRAI. At the gross margin level — before operating expenses — EXPO leads at 25. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EXPO or CRAI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CRA International, Inc. (CRAI) is the more undervalued stock at a PEG of 0. 86x versus Exponent, Inc. 's 5. 25x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, CRA International, Inc. (CRAI) trades at 18. 5x forward P/E versus 31. 2x for Exponent, Inc. — 12. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EXPO: 32. 4% to $85. 00.
08Which pays a better dividend — EXPO or CRAI?
All stocks in this comparison pay dividends.
Exponent, Inc. (EXPO) offers the highest yield at 1. 9%, versus 1. 3% for CRA International, Inc. (CRAI).
09Is EXPO or CRAI better for a retirement portfolio?
For long-horizon retirement investors, CRA International, Inc.
(CRAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), 1. 3% yield, +619. 1% 10Y return). Both have compounded well over 10 years (CRAI: +619. 1%, EXPO: +191. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EXPO and CRAI?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.